Patient Resources
Trusted resources for mental health and chronic pain: crisis support, condition organizations, and places to read primary research.
If you need help right now
Nothing on this page — or this website — is a substitute for urgent help. If you or someone near you is in crisis, use these services first, and treat any web form, including ours, as the wrong tool for an emergency.
- 988 Suicide & Crisis Lifeline — call or text 988 for free, confidential support, day or night, anywhere in the United States
- Emergency services — call 911 if there is immediate danger to you or someone else
Learning about specific conditions
These public institutions publish plain-language, regularly reviewed information about the conditions we most often evaluate. They are good first stops before — and alongside — any conversation with a clinician.
- NIMH: Depression — symptoms, treatments, and current research from the National Institute of Mental Health
- NIMH: Anxiety Disorders — an overview of anxiety conditions and evidence-based care
- NIMH: Obsessive-Compulsive Disorder (OCD) — how OCD is recognized and treated
- NIMH: Bipolar Disorder — clear explanations of bipolar conditions and treatment options
- VA National Center for PTSD — the leading public resource on post-traumatic stress, for veterans and non-veterans alike
Chronic pain
Chronic pain is a field of its own, with its own research community. If pain is part of your picture, this organization is the field's central scientific body.
- International Association for the Study of Pain (IASP) — global scientific organization for pain research, with patient-facing definitions and education
Medication safety, straight from the source
We encourage every patient to read the primary safety material on ketamine-related treatments before deciding anything. These two pages are the authoritative starting points.
- FDA safety communication on compounded ketamine — the agency's warning about potential risks of compounded ketamine products used without adequate safeguards
- Spravato REMS Program — the restricted safety program governing esketamine (Spravato), which is FDA-approved for specific depression indications
A note on using these resources
These organizations are independent of our clinic; we link to them because they are established, accountable institutions, not because we control or endorse every page they publish. Their material is educational — it cannot diagnose you, and it cannot tell you whether ketamine therapy may be considered in your situation. That conversation belongs in an evaluation, with your history on the table.
Common questions
Call or text 988 (Suicide & Crisis Lifeline) or call 911. Our website and contact forms are not monitored for emergencies, and ketamine therapy is never an emergency treatment.
Because they are public or professional institutions with editorial and clinical accountability — federal health agencies, the VA, and the pain field's scientific body — rather than commercial sites with something to sell.
No. They are excellent for education and orientation, but they cannot evaluate your history, your medications, or your risks. Use them to prepare for a conversation with a qualified clinician, not to replace one.
Sources & further reading
- 988 Suicide & Crisis Lifeline — Substance Abuse and Mental Health Services Administration. Accessed 2026-07-23.
- Depression — National Institute of Mental Health. Accessed 2026-07-23.
- Anxiety Disorders — National Institute of Mental Health. Accessed 2026-07-23.
- Obsessive-Compulsive Disorder (OCD) — National Institute of Mental Health. Accessed 2026-07-23.
- Bipolar Disorder — National Institute of Mental Health. Accessed 2026-07-23.
- National Center for PTSD — U.S. Department of Veterans Affairs. Accessed 2026-07-23.
- International Association for the Study of Pain — International Association for the Study of Pain. Accessed 2026-07-23.
- FDA warns patients and health care providers about potential risks associated with compounded ketamine products — U.S. Food and Drug Administration. Accessed 2026-07-23.
- Spravato REMS Program — Spravato REMS Program. Accessed 2026-07-23.
Links point to external organizations. Clear Ketamine Therapy does not control their content.
Keep reading
- ResearchHow we read ketamine research: what is established, what is emerging, and how primary sources shape our clinical policies.
- FAQStraight answers to the questions Tampa patients ask most: candidacy, safety, cost, insurance, sessions, and what ketamine therapy can and cannot do.
- ContactReach Clear Ketamine Therapy in Tampa. Request a consultation, ask a question, or plan a visit — with clear guidance on what not to send.
Talk with our clinical team
A consultation is a conversation, not a commitment. Ask questions, share what you are comfortable sharing, and learn whether ketamine therapy may be worth considering for you.
Not for emergencies — call or text 988 or 911 if you are in crisis.